Ai Peng: Clinical Trials

7 trials sponsored by Ai Peng, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 1 active not recruiting, 1 completed, 1 enrolling by invitation. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1

Follow Ai Peng: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients
Healthy Individuals (Controls), Vascular Surgery Patients With Acute Thrombosis
Enrolling by invitationAi Peng9002024-11-202025-08-01
Clinical and Mechanistic Research on Autogenous Arteriovenous Fistula in Hemodialysis Patients
Arteriovenous Fistula Maturation Failure in End-stage Renal Disease
Active not recruitingAi Peng1002024-10-012025-07-10
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
Gout Flare, Intercritical Gout
UnknownAi Peng6002022-09-152024-05-08
Clinical Evaluation Study of a Device for Detecting Arteriovenous Fistula Vascular Function
A device for detecting arteriovenous fistula vascular function - Arteriovenous Fistula Flow Monitoring, Early Detection of Complications of Arteriovenous Fistula
UnknownAi Peng2002022-05-012022-09-08
Role of Uralyt-U in Patients With Hyperuricemia
Febuxostat, Uralyt-U - Uric Acid Stones, Hyperuricemia
Not applicableUnknownAi Peng1022020-04-012020-04-20
The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients
Hemodialysis Complication
UnknownAi Peng2502018-01-012020-11-03
Role of CVVH in Patients With Acute Paraquat Poisoning
CVVH, Standardized therapy regimens - Poisoning by Paraquat With Undetermined Intent
CompletedAi Peng1102012-10-012016-06-14

Conditions studied

Disease (1)  ·  Hyperuricemia (1)

Interventions

Citrates (1)  ·  Febuxostat (1)

Countries

China (7)

Top investigators

Changbin Li (1)

Results publications

PMID 36261757